| HCC | Hepatocellular carcinoma |
| miRNA | MicroRNA |
| siRNA | Small interfering RNA |
| priRNA | PIWI-Interacting RNA |
| mRNA | Messenger RNA |
| HBV | Viral hepatitis B |
| HCV | Viral hepatitis C |
| ALD | Alcoholic liver disease |
| NAFLD | Nonalcoholic fatty liver disease |
| UTR | Untranslated region |
| pri-miRNA | Primary microRNA |
| DGCR8 | DiGeorge syndrome critical region gene 8 |
| TRBP | Transactivation response element RNA-binding protein |
| RISC | RNA-Induced silencing complex |
| AGO | Argonaute protein |
| OncomiR | Oncogenic miRNA |
| IL-6 | Interleukin-6 |
| TNF-α | Tumor necrosis factor-α |
| HGF | Hepatocyte growth factor |
| PTEN | Phosphatase and tensin homolog deleted on chromosome |
| RhoB | Ras homolog family member B |
| PI3K | Phosphoinositide 3-kinase |
| mTOR | Mammalian target of rapamycin |
| SMAD3 | Small mother against decapentaplegic 3 |
| TRAIL | TNF related apoptosis-inducing ligand |
| PUMA | P53 upregulated modulator of apoptosis |
| STAT3 | Signal transducer and activator of transcription 3 |
| TIMP3 | Tissue inhibitor of metalloproteinase 3 |
| NASH | Nonalcoholic steatohepatitis |
| FASN | Fatty acid synthase |
| ACC1 | Acetyl-CoA carboxylase 1 |
| IGF | Insulin-like growth factor |
| HNF | Hepatocyte nuclear factor |
| AMPK | Adenosine 5′-monophosphate-activated protein kinase |
| SIRT1 | Sirtuin 1 |
| PPAR | Peroxisome proliferator activated receptor |
| LXR | Liver X receptor |
| SREBP | Sterol regulatory element-binding protein |
| HSC | Hepatic stellate cell |
| TGF | Transforming growth factor |
| ADAM17 | A disintegrin and metalloproteinase 17 |
| TLR2 | Toll-Like receptor 2 |
| WNT | Wingless-Related integration site |
| JAK | Janus kinase |
| MAPK | Mitogen-Activated protein kinase |
| SOCS3 | Suppressor of cytokine signaling 3 |
| HBe | Hepatitis Be |
| SHIP1 | SH2-Containg inositol phosphatase 1 |
| ULK1 | Unc-51 like autophagy activating kinase 1 |
| PCBP | Poly(rC)-Binding protein |
| DLC | Deleted in liver cancer |
| IRF1 | Interferon regulatory factor 1 |
| FN | Fibronectin |
| SCD | Stearoyl-CoA desaturase |
| CREB1 | cAMP responsive element binding protein 1 |
| TRIF | TIR-Domain-Containing adapter-inducing interferon |
| HMGA2 | High-Mobility group AT-hook 2 |
| C/EBP | CCAAT/enhancer binding protein |
| KLF5 | Kruppel-Like factor 5 |
| PDK1 | Pyruvate dehydrogenase kinase 1 |
| VEGF | Vascular endothelial growth factor |
| bFGF | Basic fibroblast growth factor |
| MMP2 | Matrix metallopeptidase 2 |
| HMGB | High-Mobility group box |
| DAMP | Damaged-Associated molecular pattern |
| TP53INP1 | Tumor protein p53 inducible nuclear protein 1 |
| VFL | von Hippel-Lindau tumor suppressor |
| MLH1 | MutL homolog 1 |
| CLDN | Claudin |
| DDIT | DNA damage-inducible transcript |
| IKK | I kappa B kinase |
| TAB3 | TGF-beta activated kinase 1 binding protein 3 |
| VAV2 | Vav guanine nucleotide exchange factor 2 |
| CDC42 | Cell division cycle 42 |
| PKB | Protein kinase B |
| ROCK | RHO-Associated protein kinase |
| EMT | Epithelial-Mesenchymal transition |
| PKM2 | Pyruvate kinase M2 |
| AFP | α-fetoprotein |
| PIVKA-II | Vitamin K absence or antagonists-II |
| AMO | AntimiRNA oligonucleotide |
| LNA | Locked-Nucleic-Acid antisense oligonucleotide |
| MTg-AMO | Antagomirs and multiple-target antimiRNA antisense oligodeoxyribonucleotide |
| AAV | Adeno-Associated virus |
| TAI | Transcatheter arterial infusion |
| ABC | ATP-Binding cassette |
| KEAP1 | Kelch-Like ECH-associated protein 1 |
| NFE2L2 | Nuclear factor erythroid 2 like 2 |
| DUSP6 | Dual specificity phosphatase 6 |
| EIF4E | Eukaryotic translation initiation factor 4E |
| BRAF | v-Raf murine sarcoma viral oncogene homolog B |
| PDGFR3 | Platelet-Derived growth factor receptor 3 |
| RASSF1 | Ras association domain family member 1 |